abstract |
The present invention relates to compounds, compositions and methods which inhibit the immune response by inhibiting class II MHC-mediated activation of T cells, for example. The compounds of the present invention can be used to treat or prevent diseases such as rheumatoid arthritis and / or multiple sclerosis. |